News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups
Hosted by Robert Michel

News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups
Hosted by Robert Michel
Sign In

New Innovation Gives Clinical Pathology Laboratories Opportunity to Use Dried Blood Spot Specimens in Medical Lab Testing

Dec 16, 2011 | Laboratory Instruments & Laboratory Equipment, Laboratory News, Laboratory Operations, Laboratory Pathology

More sensitive analytical technologies allow medical laboratories to perform more sophisticated tests using tiny blood specimens on paper

New breakthroughs are creating the opportunity to use “dried blood spot” (DBS) technology in an expanded number of pathology and clinical laboratory testing applications. The latest innovation was developed in the United Kingdom and allows more sophisticated applications of this decades-old screening method.

This new technology was announced in a press release that discussed the new screening method. It was developed by a research team in the UK as a rapid method for simultaneously screening patients for a range of genetic and acquired clinical conditions from a single dried blood spot.

The team consisted of researchers at King’s College of London, together with clinicians from Guy’s and St. Thomas’ NHS Foundation Trust. The college and the two hospitals are part of King’s Health Partners, one of the UK’s five Academic Health Sciences Centers.

(more…)

Three Trends in High-Throughput Gene Sequencing for Pathologists and Clinical Laboratory Managers

Nov 16, 2011 | Laboratory Management and Operations, Laboratory News, Laboratory Pathology, Management & Operations

Two experts predict that tomorrow’s gene sequencing systems may render large swaths of today’s clinical laboratory obsolete

Gene sequencing is the hot technology in both the biotech and clinical laboratory testing industries. That is because the cost of rapid gene sequencing systems is falling rapidly, even as the speed and accuracy of these latest-generation gene sequencers improves significantly.

It is important that medical laboratories managers and pathologists understand the consequences of this technology development curve. The constantly-improving capabilities of these systems means that rapid gene sequencing and whole human genome sequencing will soon take their place in clinical laboratories and anatomic pathology groups.
(more…)

;